Eye Health Academy

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

CME/CE In-Person Event
International Congress of Scleral Contacts (ICSC) 2026
June 05, 2026
San Diego, California
Learn more
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular Health
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
- Ashkan Abbey, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Retinal Vein Occlusion: The Case for Prompt Treatment
Eye on Ocular Health
Retinal Vein Occlusion: The Case for Prompt Treatment
- Ashkan Abbey, MD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular Health
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular Health
Examining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Ophthalmology
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
- Maria H. Berrocal, MD
- Lejla Vajzovic, MD, FASRS
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Deepak Sambhara, MD
0.25 credits
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Eichenbaum, MD
0.25 credits

Clinical Practice

Identifying Central and Branch Retinal Vein Occlusion
Identifying Central and Branch Retinal Vein Occlusion
Eye on Ocular Health
Identifying Central and Branch Retinal Vein Occlusion
- Jessica Randolph, MD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- Ryan Quigley
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Esther Lee Kim, MD
0.25 credits
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
Diagnosis Delays in Stargardt Disease
Diagnosis Delays in Stargardt Disease
Ophthalmology
Diagnosis Delays in Stargardt Disease
- Alexis Warren, MD
- Jesse Sengillo, MD
- Sruthi Arepalli, MD
Practice Efficiency and Innovation
Practice Efficiency and Innovation
Modern Optometry
Practice Efficiency and Innovation
- Jacob Lang
Elevating Clinical Efficiency
Elevating Clinical Efficiency
Modern Optometry
Elevating Clinical Efficiency
- Diana Chu
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular Health
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
- Jennifer Caudle, DO, FACOFP
- Michael Javaheri, MD, MSc, FASRS

Popular

Clinical Practice

Title

Share on ReachMD